EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Real‐world use and effectiveness of fostemsavir in a US clinical setting: Insights from Trio Health HIV Research Network

Richard Elion, Cassidy Henegar iD, Isobel McEwen iD, Andrew Frick iD, Moti Ramgopal iD, Steven Santiago, Karam Mounzer, Gregory Huhn, Charles Walworth, Leigh Ragone, Vani Vannappagari iD

HIV Medicine · 2026-11 · 27 (11) · 1814-1822

DOI: 10.1111/hiv.70303 ↗

Kurz gefasst

Fachartikel in der Zeitschrift HIV Medicine, online erschienen am 22.09.2026. Verfasst von Richard Elion und 10 weiteren Autor:innen. Beteiligte Einrichtung: Analytics, Trio Health, Louisville, Colorado, USA. Hauptthemen laut MEDLINE: HIV Infections, Anti-HIV Agents, Piperazines, Organophosphates. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: ViiV Healthcare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To describe real‐world patterns of use, virologic and immunologic outcomes and treatment persistence among people with HIV (PWH) initiating fostemsavir (FTR) in a diverse US cohort.

Design

Retrospective cohort study of adults receiving FTR in clinical practice, stratified by baseline viral suppression status.

Methods

Adults with ≥1 FTR prescription between July 2020 and August 2023 were included and followed for 12 months. Individuals with trial participation were excluded. Outcomes included virologic suppression (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsAnti-HIV AgentsPiperazinesOrganophosphatesHumansRetrospective StudiesFemaleViral LoadAdultCD4 Lymphocyte CountMaleUnited StatesMiddle AgedTreatment OutcomeDrug Resistance, Viral

Stichwörter der Autor:innen

HIVantiretroviral therapydrug resistancetreatment experiencedviremiavirologically suppressed

Substanzen

fostemsavirAnti-HIV AgentsPiperazinesOrganophosphates

Autor:innen und Institutionen

  • Analytics, Trio Health, Louisville, Colorado, USA.
  • Epidemiology and Real World Evidence, Viiv Healthcare, Durham, North Carolina, USA.
  • Infectious Disease, Midway Immunology and Research Center, Fort Pierce, Florida, USA.
  • Care Resource, Miami, Florida, USA.
  • School of Medicine at the University of Pennsylvania, Philadelphia Fight Community Health Centers, Philadelphia, Pennsylvania, USA.
  • Ruth M. Rothstein CORE Center, Rush University Medical Center, Chicago, Illinois, USA.

ORCID-Profile: Cassidy Henegar, Isobel McEwen, Andrew Frick, Moti Ramgopal, Vani Vannappagari

Förderung

  • ViiV Healthcare

Zitieren

APA

Elion, R., Henegar, C., McEwen, I., Frick, A., Ramgopal, M., Santiago, S., Mounzer, K., Huhn, G., Walworth, C., Ragone, L., & Vannappagari, V. (2026). Real‐world use and effectiveness of fostemsavir in a US clinical setting: Insights from Trio Health HIV Research Network. HIV Medicine, 27(11), 1814-1822. https://doi.org/10.1111/hiv.70303

Vancouver

Elion R, Henegar C, McEwen I, Frick A, Ramgopal M, Santiago S, et al. Real‐world use and effectiveness of fostemsavir in a US clinical setting: Insights from Trio Health HIV Research Network. HIV Medicine. 2026;27(11):1814-1822. doi:10.1111/hiv.70303

BibTeX
@article{Elion2026,
  author = {Elion, Richard and Henegar, Cassidy and McEwen, Isobel and Frick, Andrew and Ramgopal, Moti and Santiago, Steven and Mounzer, Karam and Huhn, Gregory and Walworth, Charles and Ragone, Leigh and Vannappagari, Vani},
  title = {Real‐world use and effectiveness of fostemsavir in a US clinical setting: Insights from Trio Health HIV Research Network},
  journal = {HIV Medicine},
  year = {2026},
  volume = {27},
  number = {11},
  pages = {1814--1822},
  doi = {10.1111/hiv.70303}
}
Kostenlos starten →